Flash FinanceUS
Pre-market S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Eastman Chemical (EMN)

Eastman Q3 2025 adjusted EPS falls to $1.14 from $2.26 as sales drop 11%

Negative Impact 4 of 5 earnings Written later

Eastman Chemical reported third-quarter 2025 sales of $2.2 billion, down 11% from $2.46 billion a year earlier, and GAAP diluted EPS of $0.40 versus $1.53. The company attributed the decline mainly to lower sales volume, weak consumer demand, and customers reducing tariff-related inventory. It projects full-year 2025 adjusted EPS of $5.40 to $5.65 and operating cash flow approaching $1 billion, which shareholders will weigh against the sharp year-over-year drop in earnings.

Key points

  • Q3 2025 sales were $2,202 million versus $2,464 million in Q3 2024, down 11%; adjusted EBIT was $210 million versus $366 million.
  • Q3 2025 adjusted diluted EPS was $1.14 versus $2.26 a year earlier; GAAP diluted EPS was $0.40 versus $1.53.
  • Operating cash flow was $402 million, compared with $396 million in Q3 2024, helped by $204 million of inventory reduction.
  • Full-year 2025 adjusted diluted EPS is projected at $5.40 to $5.65, and the company expects to reduce costs by more than $75 million net of inflation in 2025.

The filing

CompanyEastman Chemical (EMN)
Form8-K, current report
Filed with the SECNov 3, 2025, 4:19 PM ET
Accession number0000915389-25-000176

Items reported: 2.02 Results of Operations

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 12:57 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on November 03, 2025.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.